Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
about
Ubiquitin-dependent regulation of Foxp3 and Treg functionHost immune response to infection and cancer: unexpected commonalitiesRegulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.Microenvironmental regulation of therapeutic response in cancerFc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity.Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.Beyond adjuvants: immunomodulation strategies to enhance T cell immunityImmune checkpoints: Cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 in breast cancer surgery.Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regressionAdaptive Immune Regulation of Mammary Postnatal OrganogenesisImmunity, inflammation, and cancer: an eternal fight between good and evil.CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation.Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments.Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.Transient Treg depletion enhances therapeutic anti-cancer vaccination.Immune Regulation of the Metastatic Process: Implications for Therapy.The origins and functions of dendritic cells and macrophages in the skin.Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.Overcoming tumor-mediated immunosuppression.Emerging roles of regulatory T cells in tumour progression and metastasis.Immune suppressive mechanisms in the tumor microenvironment.Targeting regulatory T cells in tumors.Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α.Cancer Immunotherapy: Whence and Whither.Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy.Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG.Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients.Emerging Opportunities and Challenges in Cancer Immunotherapy.TREG Cells in Cancer: Beyond Classical Immunological Control.Systemic Immunity Is Required for Effective Cancer Immunotherapy.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases
P2860
Q26863525-F972B197-2ACD-41C1-8C39-DB384555B368Q27015410-1550435B-1DC9-4909-BEA8-6B96461C16BEQ27310763-80D6A9F2-034F-4EAC-B079-56F8A94816FEQ30830664-3605E99B-3D9F-417D-91FF-6202C60A37AAQ33654609-419959EC-8C23-4C0C-A341-238BA6D4B2EDQ33707098-9C03D437-23C4-42D3-A79F-EF66721BE7ACQ34089124-20900E85-97E1-492E-95F1-90E93C2227C0Q34495723-53771DD0-AFBC-4E80-BD0B-D566422E42A5Q35607012-0A56E5B9-49FA-442B-AC94-EC278DE6B318Q35666506-8F510D0A-CCAC-4980-B8A3-304181100971Q35870134-99A9A8FE-E7B0-4A62-AE45-6C869689620EQ35940965-90E258E2-6B2D-4FFE-B86F-45C346423753Q36024656-F7FDB40B-4F8D-460D-9861-FE7BBC8A00B9Q36046884-3635391E-5C94-470E-99DE-C40E59BB69AAQ36060263-FAE030A5-DF28-4697-A55E-6C22C1509595Q36070571-E43C991C-9D8F-4029-A5C3-7FA332865C3CQ36106053-51490CEB-8BBF-4836-AA3A-44BCE61F7271Q36206168-03947F9F-198F-49AB-A420-3353A3DF998AQ36832278-543BB7AE-2A55-4A67-8FC0-2582493F1B57Q37162527-46FBDC9F-881B-42C7-9FAA-83B2DEE2695EQ37178662-87DDB00A-80C7-4428-A308-BB63A1FDC6ADQ37277324-FD2F86E4-90E3-49A6-9368-F80B18DDF168Q37660771-4C6CC91D-763A-4479-BBB9-75746EB8B1ABQ37719488-E67E1484-4036-442D-A034-85843C8E8659Q38214043-9ED82006-2BC2-4C06-A82D-2D7B762256ECQ38217593-A2DA6713-AFD4-40FF-BA4F-124CD16801D2Q38262255-D6891B0D-7653-402A-B04F-C5695E9DEF24Q38264092-FEA7656A-92DD-4A0A-8404-6B3A6F6679C2Q38648567-B98E38D0-C438-4D67-8757-29D1337B6E69Q38703565-8200E84E-A604-4036-BA6F-5A522AB16BFDQ38713147-95EC6804-A1F5-459A-B818-E79CD7D8A646Q38716570-2676BDF5-38E9-456B-B75B-836B3EC8FA1DQ38737924-8D40142E-77C3-484E-A0CA-CD304ED5ABC0Q38751328-A3756348-6D7F-4189-87CF-8A506C99DDDCQ38753622-034065A8-7DA5-4FD2-902E-BBF44509EBC0Q38788456-08A1F5A7-60D0-4FEF-8283-CBA1704BF192Q38809772-EAAD36C6-3025-48E6-9CAD-90AD3160A451Q38985243-52DB703A-89C5-4AE6-822F-624E1E30F14FQ39006805-BE810A84-89BF-43FC-A3C6-25D073B12059Q39109245-669E0A22-21C2-492C-A4FA-9ED17B2F6A05
P2860
Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@en
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@nl
type
label
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@en
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@nl
prefLabel
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@en
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@nl
P2093
P2860
P356
P1476
Transient regulatory T cell ab ...... cer and enhances radiotherapy.
@en
P2093
Alexander Y Rudensky
Dipayan Rudra
George Plitas
Paula D Bos
P2860
P304
P356
10.1084/JEM.20130762
P407
P577
2013-10-14T00:00:00Z